Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
16.72
-0.05 (-0.30%)
Feb 27, 2026, 3:04 PM CST

SHE:300181 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
11,59110,5457,4777,4847,0973,591
Market Cap Growth
13.31%41.03%-0.09%5.46%97.63%16.83%
Enterprise Value
11,62610,1996,7427,5367,2033,829
Last Close Price
16.7214.809.989.7710.415.20
PE Ratio
19.5320.7719.5227.4139.5640.44
Forward PE
18.1761.4161.4161.4161.4161.41
PS Ratio
4.124.093.854.154.873.29
PB Ratio
3.643.742.702.713.582.09
P/TBV Ratio
3.994.112.962.984.302.56
P/FCF Ratio
409.58308.6947.7053.2468.3416.22
P/OCF Ratio
33.2235.5025.9223.4928.1812.84
EV/Sales Ratio
4.133.963.474.184.943.51
EV/EBITDA Ratio
14.5715.5113.9519.9225.9222.35
EV/EBIT Ratio
16.0817.2715.9923.4332.1232.60
EV/FCF Ratio
410.84298.5643.0153.6269.3717.30
Debt / Equity Ratio
0.210.150.080.060.100.20
Debt / EBITDA Ratio
0.830.650.460.450.732.03
Debt / FCF Ratio
23.4112.581.421.231.991.57
Net Debt / Equity Ratio
-0.01-0.13-0.31-0.33-0.050.02
Net Debt / EBITDA Ratio
-0.04-0.57-1.78-2.43-0.330.19
Net Debt / FCF Ratio
-1.06-10.98-5.49-6.54-0.880.15
Asset Turnover
0.660.680.530.560.560.48
Inventory Turnover
2.272.141.651.811.771.80
Quick Ratio
1.421.522.042.161.131.05
Current Ratio
1.862.062.592.601.611.61
Return on Equity (ROE)
20.83%18.45%14.12%12.04%10.37%6.10%
Return on Assets (ROA)
10.61%9.69%7.25%6.29%5.37%3.25%
Return on Invested Capital (ROIC)
19.95%23.44%19.66%15.19%10.63%6.07%
Return on Capital Employed (ROCE)
21.50%20.10%14.90%11.10%10.40%6.30%
Earnings Yield
5.14%4.82%5.12%3.65%2.53%2.47%
FCF Yield
0.24%0.32%2.10%1.88%1.46%6.16%
Dividend Yield
3.58%4.05%4.51%3.07%1.92%1.92%
Payout Ratio
72.10%63.18%55.65%53.17%39.17%34.80%
Buyback Yield / Dilution
-0.12%0.10%-14.76%1.93%-1.64%-0.12%
Total Shareholder Return
3.43%4.15%-10.25%5.01%0.28%1.80%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.